Literature DB >> 22379616

Increased N-acetylaspartate in model mouse of Pelizaeus-Merzbacher disease.

Jun-ichi Takanashi1, Shigeyoshi Saito, Ichio Aoki, A James Barkovich, Yukiko Ito, Ken Inoue.   

Abstract

PURPOSE: To evaluate the N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) biochemical pathways in the brain of myelin synthesis-deficient (msd) mouse, a model of Pelizaeus-Merzbacher disease (PMD).
MATERIALS AND METHODS: We performed magnetic resonance imaging and proton magnetic resonance spectroscopy (¹H-MRS) of the thalamus for msd and wildtype mice with a 7.0 T magnet. NAA and NAAG were independently measured by high-performance liquid chromatography (HPLC). Immunohistochemical analysis using anti-Mbp, Gfap, Ng2, and NeuN antibodies were also performed.
RESULTS: ¹H-MRS in msd mice revealed increased total NAA (tNAA, NAAþNAAG), creatine, glutamine, and glutamate and decreased choline (Cho). HPLC analysis revealed increases of both NAA and NAAG in the msd brains. Histologically, the msd brains revealed hypomyelination and astrogliosis. Oligodendrocyte progenitor cells and neurons were normal in number in the thalamus wherein ¹H-MRS was obtained.
CONCLUSION: The evidence suggests that the neurochemical derangement in the msd mice may be a primary increase of NAA resulting in a secondary increase of NAAG. Increased tNAA with decreased Cho detectable on ¹H-MRS may be an important marker for PMD, and might be used to distinguish it from more common neurological disorders that have decreased tNAA.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379616     DOI: 10.1002/jmri.22817

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration.

Authors:  Joseph L McClay; Sarah A Vunck; Angela M Batman; James J Crowley; Robert E Vann; Patrick M Beardsley; Edwin J van den Oord
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-08       Impact factor: 4.147

2.  Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; Jeffrey A Stanley; James Y Garbern; Angela Trepanier; Grace Hobson; Tori Lafleur; Alexander Gow; John Kamholz
Journal:  J Neurol Sci       Date:  2013-08-30       Impact factor: 3.181

3.  Magnetic Resonance Imaging and Spectroscopy Analysis in a Pelizaeus-Merzbacher Disease Rat Model.

Authors:  Maho Ishikawa; Reika Sawaya; Miki Hirayama; Junpei Ueda; Shigeyoshi Saito
Journal:  Diagnostics (Basel)       Date:  2022-08-02

4.  Striatal N-Acetylaspartate Synthetase Shati/Nat8l Regulates Depression-Like Behaviors via mGluR3-Mediated Serotonergic Suppression in Mice.

Authors:  Yoshiaki Miyamoto; Noriyuki Iegaki; Kequan Fu; Yudai Ishikawa; Kazuyuki Sumi; Sota Azuma; Kyosuke Uno; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.